Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck

Cancer Immunology Immunotherapy

Volumn 46, Issue 3, 1998, Pages 167-173

  Bier, Henning ^a   Hoffmann, Thomas ^a   Haas, Inge ^a   Van Lierop, Anke ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antibody dependent cell mediated cytotoxicity; Epidermal growth factor receptor; Head and neck carcinoma monolayer; Monoclonal antibodies

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LEUKOCYTES, MONONUCLEAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031868728     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050475     Document Type: Article

References (36)

1. Aaronson SA (1991) Growth factors and cancer. Science 254:1146
2. Bier H, Hoffmann T (1996) Epidermal growth factor receptor in head and neck squamous cell carcinomas. In: Werner JA, Lippert BM, Rudert HH (eds) Head and neck cancer - advances in basic research. Elsevier Science, Amsterdam, p 225
3. Bier H, Reiffen KA, Haas I, Stasiecki P (1995) Dose-dependent access of murine anti-epidermal growth factor receptor monoclonal antibody to tumor cells in patients with advanced laryngeal and hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol 252:433
4. Bier H, Hoffmann T, Eickelmann P, Hafner D (1996) Chemosensitivity of head and neck squamous carcinoma cell lines is not primarily correlated with glutathione level but is modified by glutathione depletion. J Cancer Res Clin Oncol 122:653
5. Brittenden J, Heys SD, Ross J, Eremin O (1996) Natural killer cells and cancer. Cancer 77:1226
6. Carey TE (1994) Head and neck tumor cell lines. In: Hay RJ (ed) Atlas of human tumor cell lines. Academic Press, San Diego, Calif, pp 79
7. Colonna M (1997) Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 155:127
8. Eischen CM, Schilling JD, Lynch DH, Krammer PH, Leibson PL (1996) Fc receptor-induced expression of fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis. J Immunol 156:2693
9. 2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc receptors. Cancer Immunol Immunother 34:361
10. Hoffmann T, Hafner D, Ballo H, Haas I, Bier H (1997) Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines. Anticancer Res 17:4419
11. Hsuan JJ (1993) Oncogene regulation by growth factors. Anticancer Res 13:2521
12. Lanier LL, Corliss B, Phillips JH (1997) Arousal and inhibition of human NK cells. Immunol Rev 155:145
13. Lichtner RB, Harkins RN (1997) EGF receptor in tumor growth and progression. Springer, Berlin Heidelberg New York
14. Mendelsohn J (1990) The epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. Semin Cancer Biol 1:339
15. Menke AL, Shvarts A, Riteco A, van Ham RCA, Eb A van der, Jochemsen AG (1997) Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 57:1353
16. Mickel RA, Kessler DJ, Taylor JMG, Lichtenstein A (1988) Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients. Cancer Res 48:5017
17. Modjtahedi H, Styles JM, Dean CJ (1993) The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468. Br J Cancer 67:247
18. Modjtahedi H, Eccles SA, Box G, Styles JM, Dean CJ (1993) Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor receptor interaction. Br J Cancer 67:254
19. Modjtahedi H, Eccles SA, Sandle J, Box G, Titley J, Dean CJ (1994) Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor. Cancer Res 54:1695
20. Murthy U, Basu A, Rodeck U, Herlyn M, Ross A, Das M (1987) Domain-specificity and antagonistic properties of a new monoclonal antibody to the EGF-receptor. Arch Biochem Biophys 252:549
21. 2+ response patterns in target cells attacked by human natural killer cells. J Physiol (Lond) 495:319
22. Partridge LJ, Dransfield I (1993) Isolation and characterization of mononuclear phagocytes. In: Gallagher G. Rees RC, Reynolds CW (eds) Tumor immunobiology. A practical approach. Oxford University Press, Oxford, p 91
23. Ragnhammar P (1996) Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors. Med Oncol 13:167
24. Rodeck U, Herlyn M, Herlyn D, Molthoff C, Atkinson B, Varello M, Steplewski Z, Koprowski H (1987) Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically and effector cell-independent effects. Cancer Res 47:3692
25. Rubin Grandis J, Tweardy DJ (1993) Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579
26. Schantz SP, Racz T, Ordonez NG, Terry N, Taylor DL, Bugis S, Sacks PG (1989) Differential sensitivity of head and neck cancers to non-major histocompatibility-restricted killer cell activity. J Surg Res 48:154
27. Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kineses. Cell 9:383
28. Sporn MB, Roberts AB (1991) Peptide growth factors and their receptors. Springer, New York Berlin Heidelberg
29. Sporn MB, Todaro GJ (1980) Autosecretion and malignant transformation of cells. N Engl J Med 303:878
30. Sturgis EM, Sacks PG, Masui H, Mendelsohn J, Schantz SP (1994) Effects of antiepidermal growth factor receptor antibody 528 on the proliferation and differentiation of head and neck cancer. Otolaryngol Head Neck Surg 111:633
31. Sulica A, Chambers WH, Maniculea M, Metes D, Corey S, Rabinowich H, Whiteside TL, Herberman RB (1995) Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies. Nat Immun 14:123
32. Sung MW, Yasumura S, Johnson JT, Dongen GAMS van, Whiteside TL (1995) Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck. Int J Cancer 61:864
33. Sung MW, Nagashima S, Johnson JT, Dongen GAMS van, Whiteside TL (1996) The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets. Cell Immunol 171:20
34. Vuisl WMJ, Visseren MJW, Otsen M, Bos K, Vyth-Dreese FA, Figdor CG, Melief CJM, Hekman A (1993) Enhancement of the antibody-dependent cellular cytotoxicity of human peripheral blood lymphocytes with interleukin-2 and interferon α. Cancer Immunol Immunother 36:163
35. Whiteside TL, Heo DS, Takagi S, Herberman RB (1989) Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes or activated natural killer lymphocytes. In: Stevenson HC (ed) Adoptive cellular immunotherapy of cancer. Dekker, New York, p 139
36. Zenner HP, Lehner W, Herrmann I (1979) Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol 225:269